Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
3
×
editas medicine
allergan
biotech
boston
boston blog main
boston top stories
clinical trials
cynthia collins
gene editing
life sciences
national blog main
abbvie
alzheimer's disease
bill gates
bio
deals
drugs
google ventures
government
health
initial public offering
katrine bosley
leber congenital amaurosis
leber congenital amaurosis type 10
michelle robertson
parkinson's disease
rare diseases
san francisco blog main
stock market
tc
voyager therapeutics
What
editas
3
×
editing
3
×
gene
biotech
crispr
experimental
abbvie
allergan
alliance
believe
blessing
bosley
built
ceo
check
clinical
company’s
concerns
cusp
debut
depart
dispute
drop
drops
exits
far
genetic
hours
humans
ipo’s
katrine
legally
medicine
medicines
million
nearly
outfit
pact
partner
partnership
Language
unset
Current search:
editing
×
crispr
×
editas
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute